{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:58:12Z","timestamp":1790193492159,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":130,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["219S842"],"award-info":[{"award-number":["219S842"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uskudar University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The study explores the interaction between topoisomerase II\u03b2 (topo II\u03b2) and \u03b1-synuclein aggregation in Parkinson\u2019s disease (PD) using an in vitro model overexpressing A53T mutant \u03b1-synuclein, revealing key pathological features. The overexpression of A53T mutant \u03b1-synuclein was associated with impaired neuronal differentiation, accompanied by delayed neurite outgrowth and reduced levels of MAP2 and NF-L. Transcriptomic study during differentiation revealed substantial gene expression changes, with 57 of 84 PD-associated genes exhibiting differential regulation on days 8 and 12. Dopaminergic markers like TH, BDNF, NR4A2 (Nurr1), PINK1, and SYNGR3 were notably upregulated in differentiated cells, whereas A53T mutant \u03b1-synuclein overexpression was associated with significant downregulation of 22 genes associated with PD, including TH, NR4A2, BDNF, and PINK1, suggesting alterations in neuroprotective signaling pathways. Topo II\u03b2 expression diminished during differentiation in the presence of pathogenic \u03b1-synuclein and was associated with changes in the proposed topo II\u03b2-Nurr1 regulatory axis potentially contributing to early neurodevelopmental abnormalities and dopaminergic vulnerability observed in PD.<\/jats:p>","DOI":"10.1007\/s12035-026-05881-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:38:37Z","timestamp":1778485117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A53T \u03b1-Synuclein Expression is Associated with Altered Dopaminergic-Like Differentiation and Reduced DNA Topoisomerase II\u03b2 Levels in an In Vitro Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8213-5650","authenticated-orcid":false,"given":"Asl\u0131nur","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-4811","authenticated-orcid":false,"given":"Timu\u00e7in","family":"Av\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2311-8166","authenticated-orcid":false,"given":"Ye\u015fim","family":"Ne\u011fi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-6082","authenticated-orcid":false,"given":"Sevim","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"1","key":"5881_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27(1):27\u201342","journal-title":"Eur J Neurol"},{"issue":"1","key":"5881_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez GE, Zoghbi HY (2021) Parkinson\u2019s disease genetics and pathophysiology. Annu Rev Neurosci 44(1):87\u2013108","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"5881_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176","journal-title":"Cell Death Dis"},{"key":"5881_CR4","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"A Kouli","year":"2018","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB et al (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications"},{"key":"5881_CR5","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Sun Y, Song Z, Zheng W, Xiong W, Yang Y et al (2021) Genetic analysis and literature review of SNCA variants in Parkinson\u2019s disease. Front Aging Neurosci 12:13","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5881_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0329-1","volume":"14","author":"RM Meade","year":"2019","unstructured":"Meade RM, Fairlie DP, Mason JM (2019) Alpha-synuclein structure and Parkinson\u2019s disease \u2013 lessons and emerging principles. Mol Neurodegener 14(1):29","journal-title":"Mol Neurodegener"},{"issue":"4","key":"5881_CR7","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.bbrc.2015.07.007","volume":"464","author":"J Lu","year":"2015","unstructured":"Lu J, Sun F, Ma H, Qing H, Deng Y (2015) Comparison between \u03b1-synuclein wild-type and A53T mutation in a progressive Parkinson\u2019s disease model. Biochem Biophys Res Commun 464(4):988\u2013993","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"5881_CR8","first-page":"804","volume":"11","author":"L Magistrelli","year":"2021","unstructured":"Magistrelli L, Contaldi E, Comi C (2021) The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s disease 11(8):804","journal-title":"The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s disease"},{"issue":"5","key":"5881_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrc2608","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss JL (2009) DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 9(5):327\u2013337","journal-title":"Nat Rev Cancer"},{"issue":"5781","key":"5881_CR10","first-page":"1798","volume":"312","author":"BG Ju","year":"2006","unstructured":"Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK et al (2006) A topoisomerase II\u00df-mediated dsDNA break required for regulated transcription. Science (1979) 312(5781):1798\u20131802","journal-title":"Science (1979)"},{"issue":"8","key":"5881_CR11","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1074\/jbc.M008517200","volume":"276","author":"K Tsutsui","year":"2001","unstructured":"Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A (2001) Involvement of DNA topoisomerase II\u03b2 in neuronal differentiation. J Biol Chem 276(8):5769\u20135778","journal-title":"J Biol Chem"},{"issue":"5450","key":"5881_CR12","first-page":"131","volume":"287","author":"X Yang","year":"2000","unstructured":"Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) \u00a0DNA Topoisomerase II\u03b2 and neural development. Science (1979) 287(5450):131\u2013134","journal-title":"Science (1979)"},{"key":"5881_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2007.04.029","volume":"1154","author":"A Nur-E-Kamal","year":"2007","unstructured":"Nur-E-Kamal A, Meiners S, Ahmed I, Azarova A, Lin C, Lyu YL et al (2007) Role of DNA topoisomerase II\u03b2 in neurite outgrowth. Brain Res 1154:50\u201360","journal-title":"Brain Res"},{"issue":"2","key":"5881_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00277-014-2209-7","volume":"94","author":"S Isik","year":"2015","unstructured":"Isik S, Zaim M, Yildiz MT, Negis Y, Kunduraci T, Karakas N et al (2015) DNA topoisomerase II\u03b2 as a molecular switch in neural differentiation of mesenchymal stem cells. Ann Hematol 94(2):307\u2013318","journal-title":"Ann Hematol"},{"issue":"1","key":"5881_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13287-018-0859-4","volume":"9","author":"M Zaim","year":"2018","unstructured":"Zaim M, Isik S (2018) DNA topoisomerase II\u03b2 stimulates neurite outgrowth in neural differentiated human mesenchymal stem cells through regulation of Rho-GTPases (RhoA\/Rock2 pathway) and Nurr1 expression. Stem Cell Res Ther 9(1):114","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5881_CR16","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1038\/s41467-023-39970-9","volume":"14","author":"W Kim","year":"2023","unstructured":"Kim W, Tripathi M, Kim C, Vardhineni S, Cha Y, Kandi SK et al (2023) An optimized Nurr1 agonist provides disease-modifying effects in Parkinson\u2019s disease models. Nat Commun 14(1):4283","journal-title":"Nat Commun"},{"issue":"1","key":"5881_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1326-7-4","volume":"7","author":"X Heng","year":"2012","unstructured":"Heng X, Jin G, Zhang X, Yang D, Zhu M, Fu S et al (2012) Nurr1 regulates Top II\u03b2 and functions in axon genesis of mesencephalic dopaminergic neurons. Mol Neurodegener 7(1):4","journal-title":"Mol Neurodegener"},{"issue":"6","key":"5881_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/1567205014666170117103217","volume":"14","author":"S Terzioglu-Usak","year":"2017","unstructured":"Terzioglu-Usak S, Negis Y, Karabulut DS, Zaim M, Isik S (2017) Cellular model of Alzheimer\u2019s disease: A\u03b21-42 peptide induces amyloid deposition and a decrease in topo isomerase II\u03b2 and Nurr1 expression. Curr Alzheimer Res 14(6):636\u2013644","journal-title":"Curr Alzheimer Res"},{"key":"5881_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02354-w","author":"B Yeman-K\u0131yak","year":"2025","unstructured":"Yeman-K\u0131yak B, Yurdakul T, Selim A, Elibol B, Av\u015far T, Ne\u011fi\u015f Y et al (2025) Early \u03b1-synuclein pathology induces neuroinflammation and decreases topoisomerase II\u03b2 expression in A53T mice. Inflammation. https:\/\/doi.org\/10.1007\/s10753-025-02354-w","journal-title":"Inflammation"},{"issue":"6","key":"5881_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/01616412.2020.1867949","volume":"43","author":"KB Yeman","year":"2021","unstructured":"Yeman KB, Isik S (2021) Down regulation of DNA topoisomerase II\u03b2 exerts neurodegeneration like effect through Rho GTPases in cellular model of Parkinson\u2019s disease by down regulating tyrosine hydroxylase. Neurol Res 43(6):464\u2013473","journal-title":"Neurol Res"},{"key":"5881_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00328","author":"A Slanzi","year":"2020","unstructured":"Slanzi A, Iannoto G, Rossi B, Zenaro E, Constantin G (2020) In vitro models of neurodegenerative diseases. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2020.00328","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5881_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJM (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12(1):10","journal-title":"Mol Neurodegener"},{"issue":"1","key":"5881_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE et al (2017) AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease. Acta Neuropathol Commun 5(1):11","journal-title":"Acta Neuropathol Commun"},{"key":"5881_CR24","first-page":"17","volume":"31","author":"J Jiao","year":"2025","unstructured":"Jiao J, Liu W, Gao G, Yang H (2025) Serine-129 phosphorylated \u03b1-synuclein drives mitochondrial dysfunction and calcium dysregulation in Parkinson\u2019s disease model. Front Aging Neurosci 31:17","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5881_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00958-4","volume":"11","author":"K Morotomi-Yano","year":"2021","unstructured":"Morotomi-Yano K, Yano KI (2021) Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21. Sci Rep 11(1):21533","journal-title":"Sci Rep"},{"issue":"2","key":"5881_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1471-4159.2007.04494.x","volume":"102","author":"F Volpicelli","year":"2007","unstructured":"Volpicelli F, Caiazzo M, Greco D, Consales C, Leone L, Perrone-Capano C et al (2007) Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro. J Neurochem 102(2):441\u2013453","journal-title":"J Neurochem"},{"issue":"4","key":"5881_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"147","author":"X Wang","year":"2011","unstructured":"Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D et al (2011) PINK1 and parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147(4):893\u2013906","journal-title":"Cell"},{"issue":"1\u20132","key":"5881_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","volume":"77","author":"J Jankovic","year":"2005","unstructured":"Jankovic J, Chen S, Le WD (2005) The role of Nurr1 in the development of dopaminergic neurons and Parkinson\u2019s disease. Prog Neurobiol 77(1\u20132):128\u2013138","journal-title":"Prog Neurobiol"},{"issue":"7","key":"5881_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073646","volume":"23","author":"L Li","year":"2022","unstructured":"Li L, Ho PWL, Liu H, Pang SYY, Chang EES, Choi ZYK et al (2022) Transcriptional regulation of the synaptic vesicle protein synaptogyrin-3 (SYNGR3) gene: the effects of NURR1 on its expression. Int J Mol Sci 23(7):3646","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5881_CR30","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1046\/j.1471-4159.1999.0722145.x","volume":"72","author":"A Nakashima","year":"1999","unstructured":"Nakashima A, Mori K, Suzuki T, Kurita H, Otani M, Nagatsu T et al (1999) Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme. J Neurochem 72(5):2145\u20132153","journal-title":"J Neurochem"},{"issue":"2","key":"5881_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41380-021-01341-5","volume":"27","author":"MEA Reith","year":"2022","unstructured":"Reith MEA, Kortagere S, Wiers CE, Sun H, Kurian MA, Galli A et al (2022) The dopamine transporter gene SLC6A3: multidisease risks. Mol Psychiatry 27(2):1031\u20131046","journal-title":"Mol Psychiatry"},{"issue":"5\u20136","key":"5881_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00702-022-02488-3","volume":"129","author":"WD Rausch","year":"2022","unstructured":"Rausch WD, Wang F, Radad K (2022) From the tyrosine hydroxylase hypothesis of Parkinson\u2019s disease to modern strategies: a short historical overview. J Neural Transm 129(5\u20136):487\u2013495","journal-title":"J Neural Transm"},{"issue":"9","key":"5881_CR33","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/cns.12825","volume":"24","author":"X Chen","year":"2018","unstructured":"Chen X, Qian Y, Wang X, Tang Z, Xu J, Lin H et al (2018) Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia. CNS Neurosci Ther 24(9):790\u2013800","journal-title":"CNS Neurosci Ther"},{"issue":"15","key":"5881_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119","volume":"119","author":"SS Ghanem","year":"2022","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY, Poggiolini I, Santos P, Dorn A, Carloni P, Vekrellis K, Attems J, McKeith I, Outeiro TF, Jensen PH, El-Agnaf OMA (2022) \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proceedings of the National Academy of Sciences of the United States of America 119(15):e2109617119. https:\/\/doi.org\/10.1073\/pnas.2109617119","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"5881_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13041-024-01086-6","volume":"17","author":"H Suzuki","year":"2024","unstructured":"Suzuki H, Egawa N, Imamura K, Kondo T, Enami T, Tsukita K et al (2024) Mutant \u03b1-synuclein causes death of human cortical neurons via ERK1\/2 and JNK activation. Mol Brain 17(1):14","journal-title":"Mol Brain"},{"issue":"14","key":"5881_CR36","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1242\/dev.02865","volume":"134","author":"FMJ Jacobs","year":"2007","unstructured":"Jacobs FMJ, Smits SM, Noorlander CW, von Oerthel L, van der Linden AJA, Burbach JPH et al (2007) Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development 134(14):2673\u20132684","journal-title":"Development"},{"issue":"2","key":"5881_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2004.10.001","volume":"303","author":"V Baladr\u00f3n","year":"2005","unstructured":"Baladr\u00f3n V, Ruiz-Hidalgo MJ, Nueda ML, D\u00edaz-Guerra MJM, Garc\u00eda-Ram\u00edrez JJ, Bonvini E et al (2005) dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res 303(2):343\u2013359","journal-title":"Exp Cell Res"},{"issue":"2","key":"5881_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/excr.1999.4691","volume":"253","author":"\u00c5 Wall\u00e9n","year":"1999","unstructured":"Wall\u00e9n \u00c5, Zetterstr\u00f6m RH, Solomin L, Arvidsson M, Olson L, Perlmann T (1999) Fate of mesencephalic AHD2-expressing dopamine progenitor cells in Nurr1 mutant mice. Exp Cell Res 253(2):737\u2013746","journal-title":"Exp Cell Res"},{"key":"5881_CR39","doi-asserted-by":"crossref","unstructured":"Zetterstr\u00f6m RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T (1997) Dopamine neuron agenesis in Nurr1-deficient mice. Science (1979) 276(5310):248\u2013250","DOI":"10.1126\/science.276.5310.248"},{"issue":"7","key":"5881_CR40","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1046\/j.1460-9568.2003.02885.x","volume":"18","author":"SM Smits","year":"2003","unstructured":"Smits SM, Ponnio T, Conneely OM, Burbach JPH, Smidt MP (2003) Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur J Neurosci 18(7):1731\u20131738","journal-title":"Eur J Neurosci"},{"issue":"14","key":"5881_CR41","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1242\/dev.037556","volume":"136","author":"FMJ Jacobs","year":"2009","unstructured":"Jacobs FMJ, van der Linden AJA, Wang Y, von Oerthel L, Sul HS, Burbach JPH et al (2009) Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development 136(14):2363\u20132373","journal-title":"Development"},{"issue":"2","key":"5881_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/wdev.169","volume":"4","author":"S Blaess","year":"2015","unstructured":"Blaess S, Ang S (2015) Genetic control of midbrain dopaminergic neuron development. WIREs Dev Biol 4(2):113\u2013134","journal-title":"WIREs Dev Biol"},{"issue":"12","key":"5881_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70138","volume":"30","author":"M Lei","year":"2024","unstructured":"Lei M, Liu Q, Nie J, Huang R, Mei Y, Pan D, Chen Y, Liu W (2024) Impact and mechanisms of action of BDNF on neurological disorders, cancer, and cardiovascular diseases. CNS Neuroscience & Therapeutics 30(12):e70138","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"5881_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pneurobio.2007.02.001","volume":"82","author":"M Gralle","year":"2007","unstructured":"Gralle M, Ferreira ST (2007) Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 82(1):11\u201332","journal-title":"Prog Neurobiol"},{"issue":"16","key":"5881_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165724","volume":"21","author":"CA Morato Torres","year":"2020","unstructured":"Morato Torres CA, Wassouf Z, Zafar F, Sastre D, Outeiro TF, Sch\u00fcle B (2020) The role of alpha-synuclein and other Parkinson\u2019s genes in neurodevelopmental and neurodegenerative disorders. Int J Mol Sci 21(16):5724","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5881_CR46","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/cells11050851","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Li S, Wu H (2022) Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 11(5):851","journal-title":"Cells"},{"issue":"8","key":"5881_CR47","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/jnen\/nlaa056","volume":"79","author":"BM Verheijen","year":"2020","unstructured":"Verheijen BM, Morimoto S, Sasaki R, Oyanagi K, Kokubo Y, Kuzuhara S et al (2020) Expression of mutant ubiquitin and proteostasis impairment in Kii amyotrophic lateral sclerosis\/parkinsonism-dementia complex brains. J Neuropathol Exp Neurol 79(8):902\u2013907","journal-title":"J Neuropathol Exp Neurol"},{"key":"5881_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105746","volume":"123","author":"IA Lambert-Smith","year":"2020","unstructured":"Lambert-Smith IA, Saunders DN, Yerbury JJ (2020) The pivotal role of ubiquitin-activating enzyme E1 (UBA1) in neuronal health and neurodegeneration. Int J Biochem Cell Biol 123:105746","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"5881_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13024-024-00770-4","volume":"19","author":"F Xie","year":"2024","unstructured":"Xie F, Shen B, Luo Y, Zhou H, Xie Z, Zhu S et al (2024) Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson\u2019s disease: association with peripheral inflammatory regulatory T-cells and SYT6. Mol Neurodegener 19(1):80","journal-title":"Mol Neurodegener"},{"issue":"17","key":"5881_CR50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174199","volume":"134","author":"T Mathis","year":"2024","unstructured":"Mathis T, Baudin F, Mariet AS, Augustin S, Bricout M, Przegralek L, Roubeix C, Benzenine \u00c9, Blot G, Nous C, Kodjikian L, Mauget-Fa\u00ffsse M, Sahel JA, Plevin R, Zeitz C, Delarasse C, Guillonneau X, Creuzot-Garcher C, Quantin C, Hunot S, Sennlaub F (2024) DRD2 activation inhibits choroidal neovascularization in patients with parkinson\u2019s disease and age-related macular degeneration. J Clin Invest 134(17):e174199","journal-title":"J Clin Invest"},{"issue":"6","key":"5881_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2024.103694","volume":"103","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yang F, Zhu T, Zhao X, Zhang J, Wen J et al (2024) Whole genome resequencing reveals genomic regions related to red plumage in ducks. Poult Sci 103(6):103694","journal-title":"Poult Sci"},{"issue":"3","key":"5881_CR52","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3892\/etm.2017.4730","volume":"14","author":"J Pu","year":"2017","unstructured":"Pu J, Mao Y, Xu L, Zheng T, Zhang B (2017) Stable cell lines of human SH-SY5Y uniformly expressing wild-type or mutant-type FERM domain containing 7 gene. Exp Ther Med 14(3):2277\u20132283","journal-title":"Exp Ther Med"},{"issue":"9","key":"5881_CR53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s11626-024-00948-6","volume":"60","author":"IL Targett","year":"2024","unstructured":"Targett IL, Crompton LA, Conway ME, Craig TJ (2024) Differentiation of SH-SY5Y neuroblastoma cells using retinoic acid and BDNF: a model for neuronal and synaptic differentiation in neurodegeneration. In Vitro Cell Dev Biol Anim 60(9):1058\u20131067","journal-title":"In Vitro Cell Dev Biol Anim"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05881-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:02:43Z","timestamp":1778490163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05881-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5881"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05881-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"618"}}